100-fold improvement in sight seen after gene therapy trial Medical XpressAtsena Therapeutics Announces 12-Month Safety and Efficacy Data from Phase I/II Clinical Trial of ATSN-101 in LCA1 Published in The Lancet Yahoo FinanceAmerican researchers find potential cure for rare type of blindness – indica News indica NewsGene therapy restores vision in first-ever trial for rare, inherited blindness University of FloridaGene Therapy Reverses a Rare Cause of Vision Loss U.S. News & World Report